Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington's Disease.
暂无分享,去创建一个
P. Holmans | M. MacDonald | J. Long | J. Gusella | L. Jones | M. Orth | V. Wheeler | S. Kwak | D. Lucente | M. Chao | D. Monckton | M. Ciosi | Jong-Min Lee | T. Massey | E. Hong | Branduff McAllister | S. Lobanov | Thomas H. Massey | Marc Ciosi
[1] P. Holmans,et al. Huntington’s Disease Pathogenesis: Two Sequential Components , 2021, Journal of Huntington's disease.
[2] D. Monckton. The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington’s Disease: A Historical Perspective , 2021, Journal of Huntington's disease.
[3] Xiao-Qing Peng,et al. The Autism‐Related lncRNA MSNP1AS Regulates Moesin Protein to Influence the RhoA, Rac1, and PI3K/Akt Pathways and Regulate the Structure and Survival of Neurons , 2020, Autism research : official journal of the International Society for Autism Research.
[4] P. Holmans,et al. Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects. , 2020, American journal of human genetics.
[5] P. Holmans,et al. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes , 2019, EBioMedicine.
[6] Jane S. Paulsen,et al. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset , 2019, Cell.
[7] Nick C Fox,et al. MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1 , 2019, Brain : a journal of neurology.
[8] Wei Chen,et al. Statistics for X‐chromosome associations , 2018, Genetic epidemiology.
[9] L. Jones,et al. The central role of DNA damage and repair in CAG repeat diseases , 2018, Disease Models & Mechanisms.
[10] P. Holmans,et al. A modifier of Huntington's disease onset at the MLH1 locus , 2017, Human molecular genetics.
[11] D. Monckton,et al. A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients. , 2016, DNA repair.
[12] P. Holmans,et al. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases , 2016, Annals of neurology.
[13] Peter Holmans,et al. The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease. , 2016, American journal of human genetics.
[14] Jane S. Paulsen,et al. Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease , 2015, Cell.
[15] Juancarlos Chan,et al. Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..
[16] M. MacDonald,et al. Genetic modifiers of Huntington's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[17] John R Yates,et al. Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease. , 2013, Chemistry & biology.
[18] Edith T. Lopez,et al. Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches , 2013, PLoS genetics.
[19] Greg W. Clark,et al. MSH3 Polymorphisms and Protein Levels Affect CAG Repeat Instability in Huntington's Disease Mice , 2013, PLoS genetics.
[20] Jane S. Paulsen,et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion , 2012, Neurology.
[21] Audrey E Hendricks,et al. Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset. , 2009, Human molecular genetics.
[22] Edith T. Lopez,et al. Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes , 2009, Neurobiology of Disease.
[23] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[24] C. E. Pearson,et al. Repeat instability: mechanisms of dynamic mutations , 2005, Nature Reviews Genetics.
[25] G. Bates. History of genetic disease: The molecular genetics of Huntington disease — a history , 2005, Nature Reviews Genetics.
[26] Raju Kucherlapati,et al. (CAG)n-hairpin DNA binds to Msh2–Msh3 and changes properties of mismatch recognition , 2005, Nature Structural &Molecular Biology.
[27] L. Ingram,et al. Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic mosaicism: implications for the mechanism of triplet repeat expansion. , 2004, Human molecular genetics.
[28] Karen Marder,et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Trautmann,et al. ERM proteins regulate cytoskeleton relaxation promoting T cell–APC conjugation , 2004, Nature Immunology.
[30] D. Reinberg,et al. Epigenetic Dynamics of Imprinted X Inactivation During Early Mouse Development , 2004, Science.
[31] Jane S. Paulsen,et al. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. , 2003, American journal of human genetics.
[32] M. MacDonald,et al. Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease , 2003, American journal of medical genetics. Part A.
[33] M. MacDonald,et al. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. , 2003, Human molecular genetics.
[34] M. Hayden,et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.
[35] J. Penney,et al. Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.
[36] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[37] I. V. Kovtun,et al. Features of trinucleotide repeat instability in vivo , 2008, Cell Research.